Innoviva (INVA) officer has 992 shares withheld for taxes

Innoviva, Inc. (INVA) reported a routine insider transaction by its Chief Accounting Officer, who filed a Form 4 for a tax-related share withholding.

Rhea-AI Filing Summary

Innoviva, Inc. (INVA) reported a routine insider transaction by its Chief Accounting Officer, who filed a Form 4 for a tax-related share withholding. On 11/20/2025, 992 shares of common stock were withheld by Innoviva at a price of $21.16 per share to cover income tax obligations tied to the quarterly vesting of previously granted employee equity awards. After this withholding, the reporting person beneficially owned 48,337 shares of Innoviva common stock directly.

Insider Trade Summary

Exercise Price or Tax Liability: 992 shares

Exercise Price or Tax Liability 1 txn

Insider Zhen Marianne

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	992	$21.16	$21K

Holdings After Transaction: Common Stock — 48,337 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Innoviva (INVA) report in this Form 4?

Innoviva reported that its Chief Accounting Officer had 992 shares of common stock withheld on 11/20/2025 to satisfy income tax withholding obligations related to quarterly vesting of previously granted equity awards.

What was the price per share for the Innoviva (INVA) shares withheld for taxes?

The 992 shares of Innoviva common stock were withheld at a price of $21.16 per share to cover income tax withholding obligations.

How many Innoviva (INVA) shares does the reporting person own after this transaction?

Following the tax withholding transaction, the reporting person beneficially owned 48,337 shares of Innoviva common stock directly.

Why were Innoviva (INVA) shares withheld from the officer in this filing?

The filing explains that the shares were withheld by Innoviva to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

Is the Innoviva (INVA) Form 4 transaction a sale on the open market?

No. The Form 4 describes shares withheld by the issuer to cover tax obligations tied to vesting of equity awards, rather than an open-market sale initiated by the officer.

Who is the reporting person in this Innoviva (INVA) Form 4 and what is their role?

The reporting person is identified as an officer of Innoviva with the title Chief Accounting Officer, and the filing is made as a Form 4 for one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhen Marianne

(Last) (First) (Middle)

1350 OLD BAYSHORE HIGHWAY, SUITE 400

(Street)

BURLINGAME CA 94010

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innoviva, Inc. [ INVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		F		992(1)	D	$21.16	48,337	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

	/s/ Marianne Zhen	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.